Article
Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
Antiviral therapy - 1 Jan 2012
Peixoto Maíra, Mascarenhas Lays, Cunha André, Dutra Margarida, Miranda Eva, Silva Ivo, Costa Sandra, Galvão Bernardo, Cunha Andréa
Abstract excerpt
Ganciclovir (GCV) is the first therapeutic choice for prevention and treatment of active cytomegalovirus (CMV) infection in solid organ transplant recipients in Bahia state, Brazil. Prolonged and repeated GCV therapy may result in drug-resistant virus, associated with progressive and disseminated disease. We present a case report of a young male kidney recipient, who was CMV-seronegative with a CMV-seropositive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
